Glomerular filtration and associated factors in hypertensive individuals treated at primary care level;Filtração glomerular e fatores associados em hipertensos atendidos na atenção básica

Arquivos Brasileiros de Cardiologia

Volumn 94, Issue 6, 2010, Pages

  França, Ana Karina Teixeira Da Cunha ^a   Dos Santos, Alcione Miranda ^a   Calado, Isabela Leal ^a   Dos Santos, Elisângela Milhomem ^a   Cabral, Poliana Coelho ^b   Salgado, João Victor Leal ^a   Goldraich, Noemia Perli ^c   Salgado Filho, Natalino ^a  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Diet therapy; Disease prevention; Food analysis; Hypertension; Hypertension, renovascular; Kidney diseases therapy diagnosis

Indexed keywords

CREATININE; GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BRAZIL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NUTRITIONAL STATUS; OBESITY; PRIMARY MEDICAL CARE; SMOKING; WAIST CIRCUMFERENCE;

AGED; ANTHROPOMETRY; BRAZIL; CREATININE; DIABETES COMPLICATIONS; EPIDEMIOLOGIC FACTORS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; NUTRITIONAL STATUS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 77955630593     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000021     Document Type: Article

References (40)

1. Sociedade Brasileira de Cardiologia. Sociedade Brasileira de Hipertensão. Sociedade Brasileira de Nefrologia. V Diretrizes brasileiras de hipertensão arterial. Rev Bras Hipertens. 2006; 13(4):260-312.
2. Brasil. Ministério da Saúde do Brasil. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Hipertensão arterial sistêmica. n.15. Brasília; 2006.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report.JAMA. 2003; 289(19):2560-72.
4. Segura J, Campo C, Ruilope LM. How prevalent and frequent is the presence of mild renal insufficiency in essential hypertension?. J Clin Hypertens (Greenwich). 2002; 4(5):332-6.
5. New JP, Middleton RJ, Klebe B, Farmer CKT, Lusignant S, Stevens PE, et al. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med. 2007; 24(4):364-9.
6. Sociedade Brasileira de Nefrologia. Censo geral 2008.[ Acesso 2008 out.10]. Disponível em:http://www.sbn.org.br/
7. Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinina levels. J Am Soc Nephrol. 2002; 13(8):2140-4.
8. World Health Organization (WHO). Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva; 1998.
9. National Kidney Foundation - NKF. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002; 39(Suppl. 1):1-266.
10. Kramer CK, Leitão CB, Pinto LC, Silveiro SP, Gross JL, Canani LH. Clinical and laboratorial profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria. Diabetes Care. 2007; 30(8):1998-2000.
11. U.S. Renal Data System:USRDS 2001 Annual Data Report:Atlas of End-Stage Renal Disease in the United States,2001. Bethesda: National Institutes of Health, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; 2001.
12. Lessa I, Magalhães L, Araújo MJ, Almeida Filho N, Aquino E, Oliveira MMC. Hipertensão arterial na população adulta de Salvador (BA) - Brasil. Arq Bras Cardiol. 2006; 87(6):747-56.
13. Sturmer G, Dias-da-Costa JS, Olinto MTA, Menezes AMB, Gigante DP, Macedo S. O manejo não medicamentoso da hipertensão arterial sistêmica no Sul do Brasil. Cad Saúde Pública. 2006; 22(8):1727-37.
14. Fuchs FD, Gus M, Moreira LB, Moraes RS, Wiehe M, Pereira GM, et al. Anthropometric Indices and the Incidence of Hypertension: A Comparative Analysis. Obesity Research. 2005; 13(9):1515-7.
15. Costa JSD, Barcellos FC, Sclowitz ML, Sclowitz IKT, Castanheira M, Olinto MTA, et al. Prevalência de hipertensão arterial em adultos e fatores de risco associados: um estudo de base populacional urbana em Pelotas, Rio Grande do Sul, Brasil. Arq Bras Cardiol. 2007; 88(1):59-65.
16. Instituto Brasileiro de Geografia e Estatística - IBGE. Síntese de indicadores sociais: uma análise das condições de vida da população brasileira - 2008.[Acesso em 2008 ago.22]. Disponível em: 〈http://www.ibge.gov. br/home/estatistica/população/condicaodevida/indicadoresminimos/ sinteseindicsociais2008/indic-sociais2008.pdf〉
17. Boing AC, Boing AF. Hipertensão arterial sistêmica: o que nos dizem os sistemas brasileiros de cadastramentos e informações em saúde. Rev Bras Hipertens. 2007; 14(2):84-8.
18. Kearney PM, Whelton M, Reynolds K, Muntner P, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365:217-23. (Pubitemid 40138015)
19. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007; 18(10):2758-65.
20. Passos VMA, Barreto SM, Costa-Lima MFF. Detection of renal dysfunction base on serum creatinine levels in a Brazilian community. The Bambuí Health and Ageing Study. Braz J Med Biol Res. 2003; 36(3):393-401.
21. Ritz E, Ogata H, Orth SR. Smoking: a factor promoting onset and progression diabetic nephropathy. Diabetis Metab. 2000; 26(Suppl 4):S54-S63.
22. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O. Obesity and risk for chronic renal failure. Am Soc Nephrol. 2006; 17(6):1695-702.
23. Hsu C, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006; 144(1):21-8. (Pubitemid 46780716)
24. Ikitzler TA, Greene JH, WIngard RL, Parker RA, Hakim RM. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol. 1995; 6(5):1386-91.
25. Chertow GM, Hsu C, Johansen K. The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol. 2006; 17(6):1501-2. (Pubitemid 43794654)
26. World Health Organization (WHO). Physical Status: the use and interpretation of anthropometry. Geneva: 1995. (WHO Technical Report Series 854).
27. Pereira RA, Sichieri R, Marins VMR. Razão cintura/quadril como preditor de hipertensão arterial. Cad Saúde Pública. 1999; 15(2): 333-44.
28. Mulyadi L, Stevens C, Munro S, Lingard J, Bermingham M. Body fat distribution and total body fat as risk factors for microalbuminúria in the obese. Ann Nutr Metab. 2001; 45(2):67-71. (Pubitemid 32453702)
29. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, et al. Waistto- hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008; 52(1): 29-38. (Pubitemid 351853273)
30. Sociedade Brasileira de Nefrologia. Diretrizes brasileiras de doença renal crônica. J Bras Nefrol. 2004; 26(3 supl 1):1-49.
31. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes.(UK PDS33).UK Prospective Diabetes Study. (UKPDS) Group. Lancet. 1998; 352:837-53.
32. Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes. Tratamento e acompanhamento do Diabetes Mellitus. Rio de Janeiro; 2007.
33. American Diabetes Association - ADA. Standards of medical care in diabetes - 2007. Diabetes Care. 2007; 30(Suppl .1):S4-41.
34. Shemesh O, Golbetz H, Kriss JP, Meyers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985; 28(5):830-8. (Pubitemid 16156326)
35. Jungers P, Chauveau P, Descamps-Latscha B, Labrunie M, Giraud E, Man NK,et al. Age and gender related incidence of chronic renal failure in a French urban area: A prospective epidemiologic study. Nephrol Dial Transplant. 1996;11:1542-6.
36. Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD: The epidemic of aging in renal replacement therapy: An update on elderly patients and their outcomes. Clin Nephrol .2003;60:352-60.
37. Silva RP, Cisne K, Oliveira JM, Kubrusly M, Sobrinho CRMR, Andrade PJN. Dosagem de microalbuminúria em hipertensos e em pacientes portadores de doença coronariana. Arq Bras Cardiol. 2008; 90(2):108-13.
38. Stamm AMNF, Meinerz G, Silva JC. Hipertensão arterial sistêmica e microalbuminúria. Arq Bras Cardiol. 2007; 89(6):415-20.
39. Yunyun ME, Adler AI, Wareham NJ. What is the evidence that microalbuminúria is a predictor of cardiovascular disease events? Curr Opin Nephrol Hypertens. 2005; 14(3):271-6.
40. Zanella MT. Microalbuminúria: fator de risco cardiovascular e renal subestimado na prática clínica. Arq Bras Endocrinol Metab. 2006; 50(2):313-21.